Form 4: Braze Inc. General Counsel Susan Wiseman Reports Stock Transactions
SEC Form 4
Susan Wiseman, General Counsel of Braze, Inc., reports the acquisition and disposition of Class A Common Stock and the exercise of stock options.
Summary
- On July 25, 2024, Susan Wiseman, General Counsel of Braze, Inc., engaged in transactions involving the company's stock.
- Wiseman acquired 7,079 shares of Class A Common Stock through the exercise of stock options at a price of $4.88 per share.
- Concurrently, Wiseman sold 7,079 shares of Class A Common Stock at a weighted average price of $42.18 per share, with individual sales ranging from $42.00 to $42.46.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on April 11, 2024.
- Following these transactions, Wiseman directly owns 221,840 shares of Class A Common Stock and 41,425 stock options.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
The reporting person will continue to transact in the company's stock according to the pre-arranged 10b5-1 trading plan.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company executives. It is common for executives to have pre-arranged trading plans to avoid accusations of insider trading.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
- The use of Rule 10b5-1 trading plans is a common method for corporate insiders to manage their stock transactions while avoiding potential insider trading accusations, similar to practices observed at companies like Salesforce (CRM) and Adobe (ADBE).
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information being used.
Key Dates
| Date | Description |
|---|---|
| March 1, 2020 | Start date for monthly vesting of stock options. |
| February 3, 2030 | Expiration date of stock options. |
| April 11, 2024 | Date of adoption of Rule 10b5-1 trading plan. |
| July 25, 2024 | Date of stock option exercise and stock sale. |
| July 29, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.